These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9332461

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 24. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T, An T, Zwelling LA, Takano H, Fojo AT, Kleinerman ES.
    Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.
    Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S.
    J Surg Oncol; 1993 Jun; 53(2):97-103. PubMed ID: 8388965
    [Abstract] [Full Text] [Related]

  • 28. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT, Huang KY, Lin HY, Chung JG.
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [Abstract] [Full Text] [Related]

  • 29. [Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11].
    Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S.
    Noshuyo Byori; 1994 Jul; 11(1):59-64. PubMed ID: 8162152
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
    Chang JY, Liu JF, Juang SH, Liu TW, Chen LT.
    Cancer Res; 2002 Jul 01; 62(13):3716-21. PubMed ID: 12097280
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.
    Acevedo-Morantes CY, Acevedo-Morantes MT, Suleiman-Rosado D, Ramírez-Vick JE.
    Drug Deliv; 2013 Nov 01; 20(8):338-48. PubMed ID: 24024505
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of action of camptothecin.
    Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP.
    Ann N Y Acad Sci; 2000 Nov 01; 922():1-10. PubMed ID: 11193884
    [Abstract] [Full Text] [Related]

  • 35. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.
    Wang LF, Ting CY, Lo CK, Su JS, Mickley LA, Fojo AT, Whang-Peng J, Hwang J.
    Cancer Res; 1997 Apr 15; 57(8):1516-22. PubMed ID: 9108454
    [Abstract] [Full Text] [Related]

  • 36. UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice.
    Redkar AA, Meadows GG, Daoud SS.
    Int J Oncol; 2001 Jul 15; 19(1):193-9. PubMed ID: 11408942
    [Abstract] [Full Text] [Related]

  • 37. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
    Komatani H, Morita M, Sakaizumi N, Fukasawa K, Yoshida E, Okura A, Yoshinari T, Nishimura S.
    Cancer Res; 1999 Jun 01; 59(11):2701-8. PubMed ID: 10363995
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
    Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG, Boothman DA.
    Cancer Res; 1998 May 01; 58(9):1876-85. PubMed ID: 9581828
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
    van Ark-Otte J, Kedde MA, van der Vijgh WJ, Dingemans AM, Jansen WJ, Pinedo HM, Boven E, Giaccone G.
    Br J Cancer; 1998 Jun 01; 77(12):2171-6. PubMed ID: 9649129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.